Many doctors saw an alternative: wider use of an older relative of Inspra, spironolactone, a generic medicine that costs less than 20 cents a day, versus about $133 a month for Inspra.
许多医生一经发现了替代依普利酮的药品，而且比依普利酮更早出产，应用面更广。它就是安体舒通。这种药每天只需花费不到20美分。同依普利酮每月大约133美元的用费相比，它实惠很多。
The CATT data support the continued global use of intravitreal bevacizumab as an effective. low-cost alternative to ranibizumab, particularly for patients paying all costs out of pocket.
CATT研究结果支持全球继续使用玻璃体腔入路的给药途径使用倍伐单抗作为对雷珠单抗的一种廉价选择。
The CATT data support the continued global use of intravitreal bevacizumab as an effective. low-cost alternative to ranibizumab, particularly for patients paying all costs out of pocket.
CATT研究结果支持全球继续使用玻璃体腔入路的给药途径使用倍伐单抗作为对雷珠单抗的一种廉价选择。
应用推荐